{
  "id": 9395655,
  "title": "Grail's cancer blood test faces high-stakes FDA review",
  "url": "https://urgent.news/2026/09/23/grails-cancer-blood-test-faces-high-stakes-fda-review-9395655",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-23T18:40:09.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-grail-cancer-blood-high-stakes.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "A blood test designed to spot signs of multiple cancers in apparently healthy people faces its first major regulatory hurdle Wednesday as advisers to the U.S. government review how well it works.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "Winnipeg Free Press",
        "title": "Grail’s cancer blood test faces high-stakes FDA review",
        "url": "https://urgent.news/2026/09/23/grails-cancer-blood-test-faces-high-stakes-fda-review",
        "published": "2026-09-23T13:23:13.000Z"
      },
      {
        "outlet": "Quartz",
        "title": "FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance",
        "url": "https://urgent.news/2026/09/23/fda-advisers-are-voting-on-grails-multicancer-blood-test-as-medicare",
        "published": "2026-09-23T13:30:33.000Z"
      },
      {
        "outlet": "MarketWatch",
        "title": "This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval",
        "url": "https://urgent.news/2026/09/23/this-test-screens-for-50-cancers-but-whether-medicare-and-other",
        "published": "2026-09-23T18:15:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}